• Health
  • Science
  • U.S.
  • Technology
  • Business
  • World
  • Politics
  • Entertainment
  • Sports

Building a Better World

News and information

  • Home
  • Privacy Policy
  • Contact Us
  • Our Team

Government, foundations form alliance for cheaper medicine

February 10, 2014 By Contributor

Government, foundations form alliance for cheaper medicine

A new partnership aims to lower the prices of medicine.

The federal government, along with drug makers and other organizations, is forming a partnership in order to create new medicines and bring them to patients faster and cheaper. Together, these groups plan to share expertise and research data, and focus on how a disease begins and progresses.

Combining the resources of these entities will aid in finding the best point of attack for developing new medicines, according to a statement released by the newly formed organization. Organizations involved in the partnership include the U.S. National Institutes of Health (NIH), ten drug makers, and six disease-related foundations.

The partnership, “Accelerating Medicines Partnership,” will focus particularly at complex, expensive chronic disease such as Alzheimer’s and type 2 diabetes.  Studies will be aimed towards identifying biological targets that are present in a disease.  These targets can range from abnormal genes to particular proteins within the disease.

According to industry sources, almost 95 percent of experimental drugs and medicines fail.  It takes several decades and over $1 billion for a new drug to be tested and approved to be sold in the market.  Due to the fact this process is so long and costly, it limits the number of possible new medicines that drug makers can develop.  It also means that patients that are suffering from a disease, such as Alzheimer’s that has no permanent treatment, are waiting longer for better treatments and medicines to be discovered.

“Currently we are investigating a great deal of money and time in avenues with high failure rates, while patients and their families wait.  All sectors of the biomedical enterprise agree that new approaches are sorely needed,” said Dr. Francis S. Collins, Director of the NIH.

Accelerating Medicines Partnership will begin with a three-to-five-year pilot, and a budget of $230 million over the first five years.  About $130 million of the budget will go towards research on Alzheimer’s, which is a disease with no treatments other the ones that only temporarily ease symptoms.

Sharing

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Filed Under: Business, Front Page, Health, None, Science

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebookrss

Search:

Recent Posts

  • NASA’s InSight spacecraft makes important course correction May 26, 2018
  • Scientists outraged at latest Trump decision May 15, 2018
  • Huge uproar erupts over major incident at Utah park May 13, 2018
  • Incredible moon discovery stuns scientists May 12, 2018
  • Authorities shocked by discovery about common painkiller May 6, 2018
  • Outrageous crocodile experiment stuns scientists May 5, 2018
  • Great Barrier Reef is too quiet, scientists say May 1, 2018
  • Massive Hiroshima bomb discovery shocks scientists May 1, 2018
  • Earth will be slammed by massive asteroid April 29, 2018
  • Teens are doing something incredibly alarming in schools April 29, 2018
  • Huge discovery in Tasmania stuns scientists April 28, 2018
  • Shocking discovery in New Jersey stuns authorities April 22, 2018
  • Huge volcanic explosion could wipe out the United States April 21, 2018
  • Huge controversy erupts over world’s hottest pepper April 15, 2018
  • SpaceX is about to do something astonishing April 15, 2018

Copyright © 2021 Jones Kilmartin Group, LLC · Metro Pro Theme On Genesis Framework · WordPress